| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $266.3M | +31.8% |
| Cost of Revenue | $84.0M | +36.4% |
| Gross Profit | $182.3M | +32.5% |
| R&D Expense | $9.2M | +39.9% |
| SG&A Expense | $198.0M | +20.1% |
| Operating Income | -$34.4M | +30.1% |
| Pre-tax Income | -$49.8M | +19.1% |
| Income Tax | $664K | +277.3% |
| Net Income | -$50.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $87.0M | +38.4% |
| Accounts Receivable | $47.7M | +56.2% |
| Inventory | $12.2M | +10.5% |
| Current Assets | $151.3M | +34.6% |
| Total Assets | $232.6M | +23.1% |
| Current Liabilities | $63.0M | +30.4% |
| Long-term Debt | $121.5M | +1.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.0M | +47.1% |
| Capital Expenditures | $1.5M | +211.2% |
| Investing Cash Flow | -$4.8M | -196.4% |
| Financing Cash Flow | $47.4M | +6.2% |
| Free Cash Flow | -$19.5M | +43.5% |
| +18.3% |
| EPS (Basic) | -$0.81 | +25.0% |
| EPS (Diluted) | -$0.81 | +25.0% |
| Total Liabilities |
| $227.0M |
| +8.3% |
| Stockholders' Equity | $5.5M | +126.7% |